Viewing Study NCT06172907



Ignite Creation Date: 2024-05-06 @ 7:53 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06172907
Status: RECRUITING
Last Update Posted: 2024-05-14
First Post: 2023-12-07

Brief Title: A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: YAD
Brief Summary: The purpose of this pilot study is to examine the feasibility and acceptability of a brief psychotherapy intervention to improve psychosocial coping and maintain couple relationships among young adults aged 25-39 with cancer and their caregiving partners
Detailed Description: Young adults YA with cancer have unique challenges in coping and their primary partners may experience burden and low self-efficacy related to caregiving In this single-arm pilot trial the investigators shall deliver an eight-session intervention to YAs with cancer and their self-identified partners who provide caregiving The intervention is founded on principles from cognitive-behavioral therapy and couples-focused interventions tailored for YA The aim of the study is to assess the feasibility and acceptability of the intervention which will inform refinements prior to a larger-scale clinical trial This study will include 10 YAs and their partner-caregivers N20 Participants will complete surveys at baseline and after the intervention and will be invited to complete optional semi-structured exit interviews

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None